Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yabang Epson Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Yabang Group. Located in Changzhou, the company focuses on the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms across several therapeutic categories, including cardiovascular, anti-infective, and gastrointestinal health. It operates state-of-the-art, GMP-certified facilities that support large-scale manufacturing for both the Chinese domestic market and international exports. The company's portfolio includes widely used generic medications such as amlodipine, azithromycin, and omeprazole. Yabang Epson plays a vital role in the Yabang Group's integrated healthcare strategy, leveraging strong R&D and manufacturing capabilities. The company is committed to maintaining international quality standards to expand its footprint in global pharmaceutical supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Yabang Epson Pharmaceutical.